Clarkslegal’s Corporate team advise the exiting shareholders of leading human microbiome company
- 06 February 2024
- Corporate and M&A
Keep up to date with the latest tips, analysis and upcoming events by our legal experts, direct to your inbox.
Corporate lawyers, Ashan Arif and Jonathan Hayes advised the shareholders of leading human microbiome company, Invivo Healthcare, on their multi-million pound sale to Australian ASX listed business, Microba Life Sciences.
The team at Clarkslegal worked alongside, KPMG, Corporate Finance Advisers to the shareholders, to help negotiate the deal terms, support on due diligence and negotiate the key transaction documents.
Majority selling shareholder commented that: “On behalf the shareholders, I’d like to thank the Ashan, Jacob and the team at Clarkslegal for their support. I was very impressed with the manner and commerciality in which they undertook the negotiations, supporting on last minute calls and working tirelessly and expertly through challenges to get the deal done.”
I’d like to thank the Ashan, Jacob and the team at Clarkslegal for their support.
Lead lawyer, Ashan Arif, was delighted with the outcome commenting: “we were very aware of the importance of this deal to both sides. I am pleased with the manner in which all parties conducted negotiations to conclude matters pretty swiftly and overcome some quite complex challenges”.
Clarkslegal’s corporate team provide expert support to owner-managers, selling shareholders and stakeholders looking to exit their business.
Disclaimer
This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full General Notices on our website.
